INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,193 | +7.0% | 33,585 | +2.0% | 0.00% | – |
| Q4 2022 | $20,738 | -87.0% | 32,917 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $160,000 | +6.7% | 33,037 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $150,000 | -48.1% | 32,570 | +21.3% | 0.00% | -50.0% |
| Q1 2022 | $289,000 | -41.3% | 26,845 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $492,000 | +181.1% | 28,735 | +194.3% | 0.00% | +100.0% |
| Q3 2021 | $175,000 | -7.4% | 9,764 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $189,000 | – | 9,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |